Skip to content

AGIO

Agios Pharmaceuticals, Inc.

NASDAQ · USHealthcareBiotechnology
$40.06+1.14%

Price as of Jul 20, 2026

AGIO capital

Agios Pharmaceuticals, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.03x
Net debt / equity
-0.07x
Debt / assets
0.03x
Debt / EBITDA
-0.09x
Net debt / EBITDA
0.19x

Liquidity & coverage

Current ratio
14.19x
Quick ratio
13.59x
Cash ratio
12.53x
Interest coverage
EBITDA / interest
Working capital
$776.0M

Cash & dividend

FCF / debt
-10.76x
Cash flow / debt
-10.64x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.